Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial (Q33401272)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial |
scientific article |
Statements
1 reference
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial (English)
1 reference
Ian Judson
1 reference
George D Demetri
1 reference
Andrew J Wagner
1 reference
John M Goldberg
1 reference
Steven G Dubois
1 reference
Lee Rosen
1 reference
Alberto Pappo
1 reference
James Geller
1 reference
David Hogg
1 reference
Neil Senzer
1 reference
Ian J Davis
1 reference
Feng Chai
1 reference
Carol Waghorne
1 reference
17 May 2012
1 reference
1 reference
118
1 reference
23
1 reference
5894-5902
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference